<DOC>
<DOCNO>EP-0655237</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Medicinal aerosol formulation.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K	A61K900	A61K900	A61K912	A61K912	A61K972	A61K972	A61K3804	A61K3804	A61K3816	A61K3816	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K	A61K9	A61K9	A61K9	A61K9	A61K9	A61K9	A61K38	A61K38	A61K38	A61K38	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to a pharmaceutical preparation in the form of a suspension aerosol, which contains a spray-dried product which consists of a pharmaceutical substance, a surface-active physiologically tolerable substance which is insoluble in the liquified propellant, optionally a flavour corrigent and/or a customary auxiliary, in a liquefiable, hydrogenated or partly hydrogenated fluorohydrocarbon as a propellant. The invention further relates to a process for the pharmaceutical substance preparation, which contains pharmaceutical substances which are locally active on the lungs and suitable for inhalation, for the treatment of airway disorders or asthma.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST AG
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DITZINGER GUENTER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
ZOTT WOLFGANG
</INVENTOR-NAME>
<INVENTOR-NAME>
DITZINGER, GUENTER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
ZOTT, WOLFGANG
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
